CHINA GEWANG BIOTECHNOLOGY, INC. Financial Statements (2025 and earlier)
Company Profile
Business Address |
XITA 23C STAR INTERNATIONAL, 8 JINSUI GUANGZHOU PROVINCE, 510623 |
State of Incorp. | NV |
Fiscal Year End | November 30 |
Industry (SIC) | 20 - Food And Kindred Products (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
5/31/2017 MRQ | 11/30/2016 | 11/30/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments | 13,108 | 8,669 | ||||||
Cash and cash equivalents | 13,108 | 8,669 | ||||||
Inventory, net of allowances, customer advances and progress billings | 108 | 157 | ✕ | ✕ | ||||
Inventory | 108 | 157 | ||||||
Prepaid expense | 5,540 | 8 | ✕ | |||||
Other undisclosed current assets | 11,205 | 461 | ||||||
Total current assets: | 29,961 | 9,295 | ||||||
Noncurrent Assets | ||||||||
Property, plant and equipment | 129 | 66 | ||||||
Long-term investments and receivables | 6,003 | |||||||
Long-term investments | 6,003 | |||||||
Intangible assets, net (including goodwill) | 66 | ✕ | ✕ | |||||
Intangible assets, net (excluding goodwill) | 66 | |||||||
Deferred costs | 110 | |||||||
Other undisclosed noncurrent assets | 8,846 | |||||||
Total noncurrent assets: | 6,242 | 8,977 | ||||||
Other undisclosed assets | (8,912) | |||||||
TOTAL ASSETS: | 36,203 | 9,361 | ||||||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities | 4,157 | 33 | 0 | |||||
Taxes payable | 789 | |||||||
Accounts payable | 3,367 | 0 | ||||||
Accrued liabilities | 33 | |||||||
Debt | 228 | 58 | 35 | |||||
Due to related parties | 238 | |||||||
Other undisclosed current liabilities | 193 | 372 | 7 | 1 | ||||
Total current liabilities: | 4,816 | 405 | 7 | 59 | 36 | |||
Noncurrent Liabilities | ||||||||
Other undisclosed noncurrent liabilities | 190 | |||||||
Total noncurrent liabilities: | 190 | |||||||
Other undisclosed liabilities | 4,609 | |||||||
Total liabilities: | 4,816 | 5,205 | 7 | 59 | 36 | |||
Equity | ||||||||
Equity, attributable to parent, including: | 31,133 | 8,590 | (7) | (59) | (36) | |||
Common stock | 75 | 46 | 4 | 4 | 4 | |||
Additional paid in capital | 16,980 | 6,526 | 192 | 104 | 100 | |||
Accumulated other comprehensive loss | (1,707) | (252) | ||||||
Retained earnings (accumulated deficit) | 15,026 | 2,270 | (203) | |||||
Other undisclosed equity, attributable to parent | 759 | (166) | (140) | |||||
Equity, attributable to noncontrolling interest | 255 | |||||||
Other undisclosed equity | 282 | |||||||
Total equity: | 31,388 | 8,871 | (7) | (59) | (36) | |||
Other undisclosed liabilities and equity | (4,715) | |||||||
TOTAL LIABILITIES AND EQUITY: | 36,203 | 9,361 |
Income Statement (P&L) ($ in thousands)
5/31/2017 TTM | 11/30/2016 | 11/30/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|---|---|
Revenues | 45,520 | 4,184 | |||||
Revenue, net | 41,161 | ||||||
Cost of revenue (Cost of Goods and Services Sold) | (28,766) | ||||||
Other undisclosed gross profit | (1,186) | ||||||
Gross profit: | 16,754 | 2,998 | |||||
Operating expenses | (4,655) | (1,365) | (31) | (23) | (24) | ||
Other operating income, net | 1,189 | ||||||
Other undisclosed operating loss | (1,189) | ||||||
Operating income (loss): | 12,099 | 1,633 | (31) | (23) | (24) | ||
Nonoperating expense | (302) | ||||||
Loss, foreign currency transaction, before tax | (315) | ||||||
Interest and debt expense | (6) | 4 | (2) | ||||
Other undisclosed income from continuing operations before equity method investments, income taxes | 15 | ||||||
Income (loss) from continuing operations before equity method investments, income taxes: | 12,114 | 1,332 | (37) | (19) | (26) | ||
Income from equity method investments | 4,537 | ||||||
Income (loss) from continuing operations before income taxes: | 16,650 | 1,332 | (37) | (19) | (26) | ||
Income tax expense | (3,076) | (458) | |||||
Other undisclosed loss from continuing operations | (13,901) | ||||||
Income (loss) from continuing operations: | (326) | 874 | (37) | (19) | (26) | ||
Income (loss) before gain (loss) on sale of properties: | (326) | 874 | (37) | (19) | (26) | ||
Other undisclosed net income (loss) | 13,901 | 315 | (8) | ||||
Net income (loss): | 13,575 | 1,189 | (37) | (27) | (26) | ||
Net income attributable to noncontrolling interest | 62 | ||||||
Other undisclosed net loss attributable to parent | (62) | ||||||
Net income (loss) attributable to parent: | 13,575 | 1,189 | (37) | (27) | (26) | ||
Other undisclosed net loss available to common stockholders, basic | (326) | ||||||
Net income (loss) available to common stockholders, diluted: | 13,248 | 1,189 | (37) | (27) | (26) |
Comprehensive Income ($ in thousands)
5/31/2017 TTM | 11/30/2016 | 11/30/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|---|---|
Net income (loss): | 13,575 | 1,189 | (37) | (27) | (26) | ||
Other comprehensive income (loss) | (1,456) | 874 | |||||
Comprehensive income (loss): | 12,119 | 2,062 | (37) | (27) | (26) | ||
Comprehensive loss, net of tax, attributable to noncontrolling interest | (171) | (46) | |||||
Comprehensive income (loss), net of tax, attributable to parent: | 11,948 | 2,016 | (37) | (27) | (26) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.